|
Phenotype
|
Fish
|
Conditions
|
Figures
|
|
whole organism hspa5 expression increased amount, abnormal
|
wfs1bah828/ah828
|
standard conditions
|
Fig. 6
from Wang et al., 2022
|
|
whole organism hsp90b1 expression increased amount, abnormal
|
wfs1bah828/ah828
|
standard conditions
|
Fig. 6
from Wang et al., 2022
|
|
whole organism atf6 expression increased amount, abnormal
|
wfs1bah828/ah828
|
standard conditions
|
Fig. 6
from Wang et al., 2022
|
|
whole organism atf4a expression increased amount, abnormal
|
wfs1bah828/ah828
|
standard conditions
|
Fig. 6
from Wang et al., 2022
|
|
brain endoplasmic reticulum structure, abnormal
|
wfs1bah828/ah828
|
standard conditions
|
Fig. 6
from Wang et al., 2022
|
|
brain endoplasmic reticulum decreased perimeter, abnormal
|
wfs1bah828/ah828
|
standard conditions
|
Fig. 6
from Wang et al., 2022
|
|
brain endoplasmic reticulum decreased diameter, abnormal
|
wfs1bah828/ah828
|
standard conditions
|
Fig. 6
from Wang et al., 2022
|
|
brain endoplasmic reticulum decreased perimeter, abnormal
|
wfs1bah828/+
|
standard conditions
|
Fig. 6
from Wang et al., 2022
|
|
brain endoplasmic reticulum decreased diameter, abnormal
|
wfs1bah828/+
|
standard conditions
|
Fig. 6
from Wang et al., 2022
|
|
brain endoplasmic reticulum structure, abnormal
|
wfs1bah828/+
|
standard conditions
|
Fig. 6
from Wang et al., 2022
|
|
whole organism atf6 expression amount, ameliorated
|
wfs1bah828/ah828; zf206Et
|
light ablation: axon: Mauthner neuron, chemical treatment by environment: 4-phenylbutyric acid
|
Fig. 7
from Wang et al., 2022
|
|
whole organism hspa5 expression increased amount, abnormal
|
wfs1bah828/ah828; zf206Et
|
control
|
Fig. 7
from Wang et al., 2022
|
|
Mauthner neuron axon regeneration decreased process quality, abnormal
|
wfs1bah828/ah828; zf206Et
|
light ablation: axon: Mauthner neuron, chemical treatment by environment: tunicamycin
|
Fig. 7
from Wang et al., 2022
|
|
Mauthner neuron axon regeneration decreased rate of continuous process, abnormal
|
wfs1bah828/ah828; zf206Et
|
light ablation: axon: Mauthner neuron, chemical treatment by environment: tunicamycin
|
Fig. 7
from Wang et al., 2022
|
|
whole organism hsp90b1 expression increased amount, abnormal
|
wfs1bah828/ah828; zf206Et
|
control
|
Fig. 7
from Wang et al., 2022
|
|
whole organism atf6 expression increased amount, abnormal
|
wfs1bah828/ah828; zf206Et
|
control
|
Fig. 7
from Wang et al., 2022
|
|
swimming behavior decreased process quality, abnormal
|
wfs1bah828/ah828; zf206Et
|
light ablation: axon: Mauthner neuron
|
Fig. 4
from Wang et al., 2022
|
|
Mauthner neuron axon regeneration decreased rate of continuous process, abnormal
|
wfs1bah828/ah828; zf206Et
|
light ablation: axon: Mauthner neuron
|
Fig. 3
from Wang et al., 2022
|
|
Mauthner neuron axon regeneration rate of continuous process, ameliorated
|
wfs1bah828/ah828; zf206Et
|
light ablation: axon: Mauthner neuron, chemical treatment by environment: 4-phenylbutyric acid
|
Fig. 7
from Wang et al., 2022
|
|
behavioral fear response decreased process quality, abnormal
|
wfs1bah828/ah828; zf206Et
|
light ablation: axon: Mauthner neuron
|
Fig. 4
from Wang et al., 2022
|
|
whole organism hsp90b1 expression increased amount, abnormal
|
wfs1bah828/ah828; zf206Et
|
light ablation: axon: Mauthner neuron, chemical treatment by environment: tunicamycin
|
Fig. 7
from Wang et al., 2022
|
|
whole organism hsp90b1 expression amount, ameliorated
|
wfs1bah828/ah828; zf206Et
|
light ablation: axon: Mauthner neuron, chemical treatment by environment: 4-phenylbutyric acid
|
Fig. 7
from Wang et al., 2022
|
|
Mauthner neuron axon regeneration process characteristic, ameliorated
|
wfs1bah828/ah828; zf206Et
|
light ablation: axon: Mauthner neuron, chemical treatment by environment: 4-phenylbutyric acid
|
Fig. 7
from Wang et al., 2022
|
|
Mauthner neuron axon regeneration decreased rate of continuous process, abnormal
|
wfs1bah828/ah828; zf206Et
|
control
|
Fig. 7
from Wang et al., 2022
|
|
whole organism atf6 expression increased amount, abnormal
|
wfs1bah828/ah828; zf206Et
|
light ablation: axon: Mauthner neuron, chemical treatment by environment: tunicamycin
|
Fig. 7
from Wang et al., 2022
|
|
Mauthner neuron axon regeneration decreased process quality, abnormal
|
wfs1bah828/ah828; zf206Et
|
control
|
Fig. 7
from Wang et al., 2022
|
|
whole organism hspa5 expression amount, ameliorated
|
wfs1bah828/ah828; zf206Et
|
light ablation: axon: Mauthner neuron, chemical treatment by environment: 4-phenylbutyric acid
|
Fig. 7
from Wang et al., 2022
|
|
whole organism hspa5 expression increased amount, abnormal
|
wfs1bah828/ah828; zf206Et
|
light ablation: axon: Mauthner neuron, chemical treatment by environment: tunicamycin
|
Fig. 7
from Wang et al., 2022
|
|
Mauthner neuron axon regeneration decreased process quality, abnormal
|
wfs1bah828/ah828; zf206Et
|
light ablation: axon: Mauthner neuron
|
Fig. 3
from Wang et al., 2022
|
|
whole organism hmgcs1 expression decreased amount, abnormal
|
wfs1aah829/ah829; wfs1bah828/ah828 (AB)
|
standard conditions
|
Figure 4
from Tang et al., 2026
|
|
Mauthner neuron axon increased ratio oligodendrocyte myelin sheath, abnormal
|
wfs1aah829/ah829; wfs1bah828/ah828 (AB)
|
standard conditions
|
Figure 3
from Tang et al., 2026
|
|
whole organism plp1b expression decreased amount, abnormal
|
wfs1aah829/ah829; wfs1bah828/ah828 (AB)
|
standard conditions
|
Figure 3
from Tang et al., 2026
|
|
whole organism Ab1-hmgcs1 labeling decreased amount, abnormal
|
wfs1aah829/ah829; wfs1bah828/ah828 (AB)
|
standard conditions
|
Figure 4
from Tang et al., 2026
|
|
whole organism mbpa expression decreased amount, abnormal
|
wfs1aah829/ah829; wfs1bah828/ah828 (AB)
|
standard conditions
|
Figure 3
from Tang et al., 2026
|
|
whole organism Ab13-mbp labeling decreased amount, abnormal
|
wfs1aah829/ah829; wfs1bah828/ah828 (AB)
|
standard conditions
|
Figure 3
from Tang et al., 2026
|
|
whole organism mag expression decreased amount, abnormal
|
wfs1aah829/ah829; wfs1bah828/ah828 (AB)
|
standard conditions
|
Figure 3
from Tang et al., 2026
|
|
swimming behavior decreased process quality, abnormal
|
wfs1aah829/ah829; wfs1bah828/ah828 (AB)
|
standard conditions
|
Figure 1
from Tang et al., 2026
|
|
eye decreased area, abnormal
|
wfs1aah829/ah829; wfs1bah828/ah828 (AB)
|
standard conditions
|
Figure 1
from Tang et al., 2026
|
|
whole organism mpz expression decreased amount, abnormal
|
wfs1aah829/ah829; wfs1bah828/ah828 (AB)
|
standard conditions
|
Figure 3
from Tang et al., 2026
|
|
heart heart contraction decreased rate of continuous process, abnormal
|
wfs1aah829/ah829; wfs1bah828/ah828 (AB)
|
standard conditions
|
Figure 1
from Tang et al., 2026
|
|
whole organism Ab38-gapdh labeling decreased amount, abnormal
|
wfs1aah829/ah829; wfs1bah828/ah828 (AB)
|
standard conditions
|
Figure 4
from Tang et al., 2026
|
|
oligodendrocyte amount, ameliorated
|
wfs1aah829/ah829; wfs1bah828/ah828; vu12Tg (AB)
|
chemical treatment by injection: geranylgeraniol
|
Figure 6
from Tang et al., 2026
|
|
oligodendrocyte hmgcs1 expression decreased amount, abnormal
|
wfs1aah829/ah829; wfs1bah828/ah828; vu12Tg (AB)
|
standard conditions
|
Figure 5
from Tang et al., 2026
|
|
oligodendrocyte mbpa expression decreased amount, abnormal
|
wfs1aah829/ah829; wfs1bah828/ah828; vu12Tg (AB)
|
standard conditions
|
Figure 5
from Tang et al., 2026
|
|
oligodendrocyte plp1b expression decreased amount, abnormal
|
wfs1aah829/ah829; wfs1bah828/ah828; vu12Tg (AB)
|
standard conditions
|
Figure 5
from Tang et al., 2026
|
|
oligodendrocyte decreased amount, abnormal
|
wfs1aah829/ah829; wfs1bah828/ah828; vu12Tg (AB)
|
standard conditions
|
Figure 2 ,
Figure 6
from Tang et al., 2026
|
|
oligodendrocyte mpz expression decreased amount, abnormal
|
wfs1aah829/ah829; wfs1bah828/ah828; vu12Tg (AB)
|
standard conditions
|
Figure 5
from Tang et al., 2026
|
|
oligodendrocyte mag expression decreased amount, abnormal
|
wfs1aah829/ah829; wfs1bah828/ah828; vu12Tg (AB)
|
standard conditions
|
Figure 5
from Tang et al., 2026
|